This contract supports advanced development of a multivalent filovirus (biodefense) vaccine that could address both Ebola and Marburg viruses; support may be provided through early clinical development of the filovirus vaccine candidate.
IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
-
Activity
N01
-
Administering IC
AI
-
Application Type
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
4000000
-
Sub Project Total Cost
-
ARRA Funded
False
-
CFDA Code
855
-
Ed Inst. Type
-
Funding ICs
NIAID:4000000\
-
Funding Mechanism
Non SBIR/STTR Contracts
-
Study Section
-
Study Section Name